Latest filing published 05 Mar 2025 for Novonesis (Novozymes A/S), €59k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Cees de Jong: trading record in brief
This profile gathers the share dealings of Cees de Jong in Novonesis (Novozymes A/S). In total, 3 filings cover trades dated from 27 January 2023 to 5 March 2025.
Every open-market trade on record is a purchase: 3 purchases worth €200k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2025: 1 purchase and no sales on the market.
Half of the purchases are above €59k and half below. No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The record was last updated on 5 March 2025 with an open-market purchase (€59k) in Novonesis (Novozymes A/S). Most trades are made public on the day they happen. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.
Companies and markets linked to Cees de Jong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ DKK 439.500.0% of flowShareXCSEISIN DK0060336014DK:1347062Canonical exit: 3 Jun 2025 (T+90)
- 1,000 shares@ DKK 361.04290.0% of flowShareCopenhagen Stock ExchangeISIN DK0060336014DK:1204685Canonical exit: 3 May 2023 (T+90)
- 2,000 shares@ DKK 344.61610.0% of flowShareCopenhagen Stock ExchangeISIN DK0060336014DK:1203501Canonical exit: 27 Apr 2023 (T+90)
3 of 3 declarations